These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

861 related items for PubMed ID: 28466266

  • 21. Inhibition of Microglia-Derived Oxidative Stress by Ciliary Neurotrophic Factor Protects Dopamine Neurons In Vivo from MPP⁺ Neurotoxicity.
    Baek JY, Jeong JY, Kim KI, Won SY, Chung YC, Nam JH, Cho EJ, Ahn TB, Bok E, Shin WH, Jin BK.
    Int J Mol Sci; 2018 Nov 10; 19(11):. PubMed ID: 30423807
    [Abstract] [Full Text] [Related]

  • 22. Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcγR I and TLR4 pathways.
    Zhang J, Niu N, Wang M, McNutt MA, Zhang D, Zhang B, Lu S, Liu Y, Liu Z.
    Int J Biochem Cell Biol; 2013 Aug 10; 45(8):1911-20. PubMed ID: 23791745
    [Abstract] [Full Text] [Related]

  • 23. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA, Connor B, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2000 Nov 10; 166(1):1-15. PubMed ID: 11031079
    [Abstract] [Full Text] [Related]

  • 24. Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat.
    Ambrosi G, Kustrimovic N, Siani F, Rasini E, Cerri S, Ghezzi C, Dicorato G, Caputo S, Marino F, Cosentino M, Blandini F.
    Neurotox Res; 2017 Jul 10; 32(1):71-81. PubMed ID: 28285346
    [Abstract] [Full Text] [Related]

  • 25. Extracellular Zn2+ Influx into Nigral Dopaminergic Neurons Plays a Key Role for Pathogenesis of 6-Hydroxydopamine-Induced Parkinson's Disease in Rats.
    Tamano H, Nishio R, Morioka H, Takeda A.
    Mol Neurobiol; 2019 Jan 10; 56(1):435-443. PubMed ID: 29705946
    [Abstract] [Full Text] [Related]

  • 26. A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C).
    Smith GA, Rocha EM, Rooney T, Barneoud P, McLean JR, Beagan J, Osborn T, Coimbra M, Luo Y, Hallett PJ, Isacson O.
    PLoS One; 2015 Jan 10; 10(3):e0121072. PubMed ID: 25815475
    [Abstract] [Full Text] [Related]

  • 27. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R, Singh N, Lawana V, Ghosh A, Harischandra DS, Jin H, Hogan C, Sarkar S, Rokad D, Panicker N, Anantharam V, Kanthasamy AG, Kanthasamy A.
    Neurobiol Dis; 2016 Sep 10; 93():96-114. PubMed ID: 27151770
    [Abstract] [Full Text] [Related]

  • 28. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
    Deng I, Corrigan F, Garg S, Zhou XF, Bobrovskaya L.
    Int J Mol Sci; 2021 Jul 09; 22(14):. PubMed ID: 34299000
    [Abstract] [Full Text] [Related]

  • 29. Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions.
    Kramer BC, Mytilineou C.
    J Neurocytol; 2004 Mar 09; 33(2):213-23. PubMed ID: 15322379
    [Abstract] [Full Text] [Related]

  • 30. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y, Kurosaki R, Watanabe H, Michimata M, Matsubara M, Imai Y, Araki T.
    Glia; 2003 May 09; 42(3):307-13. PubMed ID: 12673835
    [Abstract] [Full Text] [Related]

  • 31. Adaptation within mitochondrial oxidative phosphorylation supercomplexes and membrane viscosity during degeneration of dopaminergic neurons in an animal model of early Parkinson's disease.
    Kuter K, Kratochwil M, Berghauzen-Maciejewska K, Głowacka U, Sugawa MD, Ossowska K, Dencher NA.
    Biochim Biophys Acta; 2016 Apr 09; 1862(4):741-753. PubMed ID: 26844379
    [Abstract] [Full Text] [Related]

  • 32. AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo.
    Saal KA, Koch JC, Tatenhorst L, Szegő EM, Ribas VT, Michel U, Bähr M, Tönges L, Lingor P.
    Neurobiol Dis; 2015 Jan 09; 73():150-62. PubMed ID: 25283984
    [Abstract] [Full Text] [Related]

  • 33. Effect of Intrastriatal 6-OHDA Lesions on Extrastriatal Brain Structures in the Mouse.
    Becker B, Demirbas M, Johann S, Zendedel A, Beyer C, Clusmann H, Haas SJ, Wree A, Tan SKH, Kipp M.
    Mol Neurobiol; 2018 May 09; 55(5):4240-4252. PubMed ID: 28616718
    [Abstract] [Full Text] [Related]

  • 34. Microglial cells are involved in the susceptibility of NADPH oxidase knockout mice to 6-hydroxy-dopamine-induced neurodegeneration.
    Hernandes MS, Santos GD, Café-Mendes CC, Lima LS, Scavone C, Munhoz CD, Britto LR.
    PLoS One; 2013 May 09; 8(9):e75532. PubMed ID: 24086556
    [Abstract] [Full Text] [Related]

  • 35. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.
    McCoy MK, Martinez TN, Ruhn KA, Szymkowski DE, Smith CG, Botterman BR, Tansey KE, Tansey MG.
    J Neurosci; 2006 Sep 13; 26(37):9365-75. PubMed ID: 16971520
    [Abstract] [Full Text] [Related]

  • 36. Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestoration.
    'Episcopo FL, Tirolo C, Testa N, Caniglia S, Morale MC, Marchetti B.
    Curr Aging Sci; 2013 Feb 13; 6(1):45-55. PubMed ID: 23895521
    [Abstract] [Full Text] [Related]

  • 37. 6-Hydroxydopamine as a tool to understand adaptive immune system-induced dopamine neurodegeneration in Parkinson's disease.
    Theodore S, Maragos W.
    Immunopharmacol Immunotoxicol; 2015 Feb 13; 37(4):393-9. PubMed ID: 26211726
    [Abstract] [Full Text] [Related]

  • 38. Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease.
    Harms AS, Barnum CJ, Ruhn KA, Varghese S, Treviño I, Blesch A, Tansey MG.
    Mol Ther; 2011 Jan 13; 19(1):46-52. PubMed ID: 20959812
    [Abstract] [Full Text] [Related]

  • 39. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
    Pang Y, Lin S, Wright C, Shen J, Carter K, Bhatt A, Fan LW.
    Neuroscience; 2016 Mar 24; 318():157-65. PubMed ID: 26777890
    [Abstract] [Full Text] [Related]

  • 40. Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression.
    Wang Y, Wang Q, Yu R, Zhang Q, Zhang Z, Li H, Ren C, Yang R, Niu H.
    Aging (Albany NY); 2020 Jul 24; 12(14):14232-14243. PubMed ID: 32706757
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.